Blog

Many of the opioid-related lawsuits have resulted in the public disclosure of previously confidential documents. These have been archived through a collaboration between Johns Hopkins and UCSF. See what’s in the archive and how you can access it.

A recent survey of people who use drugs led by the Bloomberg School of Public Health’s Bloomberg Overdose Prevention Initiative found that harm reduction organizations continued to provide critical services to clients throughout the COVID-19 pandemic despite significant operational challenges. Hear what overdose survivors had to say about the importance of harm reduction.

New regulations from the Drug Enforcement Administration make it much easier to operate mobile methadone vans. We talked to Jason Brian Gibbons to learn more about these vans, how they can expand access to this evidence-based treatment, and whether they could be a wise investment of opioid litigation funds.

Despite passing legislation in 2019 related to the opioid litigation, Maryland wasn’t yet done. In 2022, state legislators passed two additional bills to ensure that the state was prepared for the influx of dollars.

States, cities and counties will receive a lot of money from the opioid litigation over the next 18 years. How does this money compare to the money that they’re currently receiving from the federal government to combat substance use?

Prescribing naloxone to people at high-risk for an opioid overdose is an evidence-based approach to reduce overdose deaths. Yet naloxone prescription rates remain low. A number of states have passed laws to try and address this–see what happened in one health system in California as a result.

Curious about the status of all the lawsuits? Want to see what is happening across states? This website is the place for you.

Researchers interviewed staff in New Jersey correctional facilities and found three key lessons from the recent expansion of treatment in jails across the state.